Liquidia and United Therapeutics have entered into a global settlement that ends a yearslong legal dispute over Yutrepia, Liquidia’s dry powder inhalation formulation of the medication treprostinil. Under the settlement, Liquidia will maintain access to Yutrepia for people with pulmonary arterial hypertension (PAH), but pull the…

Living with pulmonary hypertension (PH) involves much more than managing symptoms, taking medications, and attending medical appointments. There is also an emotional side to chronic illness that can be difficult to explain, even to the people closest to us. I know how much energy it takes to manage a…

If you’re in the United States, you probably know there’s an election happening on Nov. 3. Local, state, and federal candidates are all vying for elected office with big ideas on why they should serve and represent their constituents next term. You might even be annoyed by all the candidate…